Drug
Trelagliptin 100 mg
Trelagliptin 100 mg is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Active, not recruiting2
Completed1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (25.0%)
N/A3 (75.0%)
Trials by Status
completed125%
enrolling_by_invitation125%
active_not_recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
enrolling_by_invitationphase_3
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
NCT07073768
active_not_recruitingnot_applicable
Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
NCT06913101
active_not_recruitingnot_applicable
Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
NCT06889909
completednot_applicable
Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers
NCT03362398
Clinical Trials (4)
Showing 4 of 4 trials
NCT07073768Phase 3
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
NCT06913101Not Applicable
Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
NCT06889909Not Applicable
Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
NCT03362398Not Applicable
Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4